Skip to content
Screener

Utah Medical Products UTMD Q2 2026 earnings

Reported July 23, 2026 · Before market open

Revenue$8.5M
EPS$0.84

Next report

Oct 22, 2026 (In 1 week)

Financials

Q2 2026

Income statement

See full
Revenue$8.5M-14.3%
Gross profit$4.8M-15.0%
Operating income$2.6M-17.1%
Net income$2.7M-11.9%
EPS (diluted)$0.84-10.6%

Balance sheet

See full
Cash & equivalents$87.5M+6.5%
Total debt$195.0K-23.8%
Total equity$122.0M+3.8%
Total assets$124.6M+3.1%

Cash flow

See full
Operating cash flow$1.4M-51.9%
CapEx$134.0K+163%
Free cash flow$1.2M-55.7%

Valuation & ratios

Valuation

as of 10/12/26
See full
Market cap$236.58M+21.9%
Enterprise value$149.24M+35.7%
P/E22.6×+5.9×
P/S6.6×+1.5×

Profitability

See full
Gross margin57.9%+0.6pp
Operating margin28.4%-4.1pp
Net margin29%-3.3pp
FCF margin31.7%-3.8pp

Returns & leverage

See full
Return on equity8.8%-1.6pp
Debt / equity0×0.0×
Current ratio48.6×+6.7×

Segments

By product

See full
Gynecology/Electrosurgery/Urology$4.3M-11.0%
Neonatal$1.9M-8.7%
Blood Pressure Monitoring and Accessories$1.3M-37.4%
Obstetrics$1.1M+4.0%

FAQ

When did Utah Medical Products report Q2 2026 earnings?
Utah Medical Products (UTMD) reported Q2 2026 earnings on July 23, 2026 before market open.
What were Utah Medical Products's Q2 2026 revenue and EPS?
Utah Medical Products reported revenue of $8.5M and eps of $0.84 for Q2 2026.
How did Utah Medical Products's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 14.3% from $10.0M a year earlier and eps declined 10.6% from $0.94.
Where can I find Utah Medical Products's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001096906-26-001112) and the 10-Q periodic report (0001096906-26-001210) directly on SEC EDGAR. The filing index links above go to sec.gov.